GENEVA, Jan. 22 (Xinhua) -- Unitaid, a global health initiative that works with partners to bring about innovations to prevent, diagnose and treat major diseases in low and middle income countries (LMICs), and the Foundation for Innovative New Diagnostics (FIND) on Friday announced that they have finalized an agreement to cut in half the costs of antigen-detecting rapid diagnostic tests.
In a media statement released Friday, Unitaid and FIND also declared that they will increase capacity to produce "264 million test kits" during "the coming 12 months."
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
